The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics
Open accessAbstract
The extracellular matrix (ECM) is an abundant noncellular component of most solid tumors known to support tumor progression and metastasis. The interplay between the ECM and cancer therapeutics opens up new avenues in understanding cancer biology. While the ECM is known to protect the tumor from anticancer agents by serving as a biomechanical barrier, emerging studies show that various cancer therapies induce ECM remodeling, resulting in therapy resistance and tumor progression. This review discusses critical issues in this field including how the ECM influences treatment outcome, how cancer therapies affect ECM remodeling, and the challenges associated with targeting the ECM. Significance: The intricate relationship between the extracellular matrix (ECM) and cancer therapeutics reveals novel insights into tumor biology and its effective treatment. While the ECM may protect tumors from anti-cancer agents, recent research highlights the paradoxical role of therapy-induced ECM remodeling in promoting treatment resistance and tumor progression. This review explores the key aspects of the interplay between ECM and cancer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kessenbrock, K., Plaks, V., & Werb, Z. (2010) · Cell · doi:10.1016/j.cell.2010.03.015 · Cited by 5,151
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Macrophages as regulators of tumour immunity and immunotherapy
DeNardo, D. G., & Ruffell, B. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0127-6 · Cited by 2,528
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Effects of extracellular matrix viscoelasticity on cellular behaviour
Chaudhuri, O., Cooper-White, J., Janmey, P. A., Mooney, D. J., & Shenoy, V. B. (2020) · Nature · doi:10.1038/s41586-020-2612-2 · Cited by 2,224
The Tumour Microenvironment after Radiotherapy: Mechanisms of Resistance and Recurrence
Barker, H. E., Paget, J. T. E., Khan, A. A., & Harrington, K. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3958 · Cited by 2,144 · cited 4×
“Similarly, cancer cells produce proteolytic enzymes following exposure to radiation which support their aggressiveness and resistance to therapy (69).”
BackgroundInfluentialFeig, C., Jones, J. O., Kraman, M., Wells, R. J. B., Deonarine, A., Chan, D. S., Connell, C. M., Roberts, E. W., Zhao, Q., Caballero, O. L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320318110 · Cited by 2,100 · cited 1×
“Studies have suggested that these effects are mainly mediated by CXCL12/CXCR4-dependent immunosuppressive immune cells, suggesting that targeting CXCR4 along with ICI therapy may result in improved outcomes (56).”
BackgroundGaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J. F., Harrington, K., & Sahai, E. (2007) · Nature Cell Biology · doi:10.1038/ncb1658 · Cited by 1,589 · cited 2×
“The blockade of integrin α 3, α 5, or Rho-Rock function in CAFs reduces the formation of these tracks and hampers cancer cell invasion (10).”
BackgroundNeutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
Albrengues, J., Shields, M. A., Ng, D., Park, C. G., Ambrico, A., Poindexter, M. E., Upadhyay, P., Uyeminami, D. L., Pommier, A., Küttner, V., et al. (2018) · Science · doi:10.1126/science.aao4227 · Cited by 1,476
Naba, A., Clauser, K. R., Hoersch, S., Liu, H., Carr, S. A., & Hynes, R. O. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.014647 · Cited by 1,354
Overview of the Matrisome--An Inventory of Extracellular Matrix Constituents and Functions
Hynes, R. O., & Naba, A. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004903 · Cited by 1,349
Myofibroblast contraction activates latent TGF-β1 from the extracellular matrix
Wipff, P.-J., Rifkin, D. B., Meister, J.-J., & Hinz, B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200704042 · Cited by 1,346
Interactions between cancer stem cells and their niche govern metastatic colonization
Malanchi, I., Santamaria-Martínez, A., Susanto, E., Peng, H., Lehr, H.-A., Delaloye, J.-F., & Huelsken, J. (2012) · Nature · doi:10.1038/nature10694 · Cited by 1,339
Diversity and biology of cancer-associated fibroblasts
Biffi, G., & Tuveson, D. A. (2021) · Physiological Reviews · doi:10.1152/physrev.00048.2019 · Cited by 1,265
Daynes, R. A., Araneo, B. A., Ershler, W. B., Maloney, C., Li, G. Z., & Ryu, S. Y. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5219 · Cited by 1,264
Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Le, Q.-T., & Giaccia, A. J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.11.012 · Cited by 1,231
Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
Cox, T. R. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-020-00329-7 · Cited by 976
Pancreatic cancer stroma: an update on therapeutic targeting strategies
Hosein, A. N., Brekken, R. A., & Maitra, A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0300-1 · Cited by 950
Wei, S. C., Fattet, L., Tsai, J. H., Guo, Y., Pai, V. H., Majeski, H. E., Chen, A. C., Sah, R. L., Taylor, S. S., Engler, A. J., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3157 · Cited by 948
Modelling cancer in microfluidic human organs-on-chips
Sontheimer-Phelps, A., Hassell, B. A., & Ingber, D. E. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0104-6 · Cited by 906 · cited 1×
“Therefore, patient-relevant 3D in vitro models based on complex hetero-spheroids, cancer-on-chip models, 3D bioprinting techniques are required to recapitulate human tumor stroma interaction and human tumor ECM (98, 99).”
BackgroundNia, H. T., Munn, L. L., & Jain, R. K. (2020) · Science · doi:10.1126/science.aaz0868 · Cited by 855
Schrader, J., Gordon-Walker, T. T., Aucott, R. L., van Deemter, M., Quaas, A., Walsh, S., Benten, D., Forbes, S. J., Wells, R. G., & Iredale, J. P. (2011) · Hepatology · doi:10.1002/hep.24108 · Cited by 720
Fibrosis and cancer: A strained relationship
Piersma, B., Hayward, M.-K., & Weaver, V. M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188356 · Cited by 680
Cancer-associated fibroblasts in the single-cell era
Lavie, D., Ben-Shmuel, A., Erez, N., & Scherz-Shouval, R. (2022) · Nature Cancer · doi:10.1038/s43018-022-00411-z · Cited by 616
The extracellular matrix in tumor progression and metastasis
Eble, J. A., & Niland, S. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09966-1 · Cited by 613 · cited 1×
“ECM remodeling in tumor tissues can regulate cellular interactions by eliciting biochemical signals which can further support cancer progression, metastasis, and dormancy (34, 35).”
BackgroundA timeline of tumour-associated macrophage biology
Cassetta, L., & Pollard, J. W. (2023) · Nature Reviews Cancer · doi:10.1038/s41568-022-00547-1 · Cited by 581
Comito, G., Giannoni, E., Segura, C. P., Barcellos-de-Souza, P., Raspollini, M. R., Baroni, G., Lanciotti, M., Serni, S., & Chiarugi, P. (2014) · Oncogene · doi:10.1038/onc.2013.191 · Cited by 528
Hingorani, S. R., Zheng, L., Bullock, A. J., Seery, T. E., Harris, W. P., Sigal, D. S., Braiteh, F., Ritch, P. S., Zalupski, M. M., Bahary, N., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.9564 · Cited by 510
Combining two strategies to improve perfusion and drug delivery in solid tumors
Stylianopoulos, T., & Jain, R. K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318415110 · Cited by 508
Van Cutsem, E., Tempero, M. A., Sigal, D., Oh, D.-Y., Fazio, N., Macarulla, T., Hitre, E., Hammel, P., Hendifar, A. E., Bates, S. E., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.00590 · Cited by 499
Auvinen, P., Tammi, R., Parkkinen, J., Tammi, M., Ågren, U., Johansson, R., Hirvikoski, P., Eskelinen, M., & Kosma, V.-M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64757-8 · Cited by 493
Peng, D. H., Rodriguez, B. L., Diao, L., Chen, L., Wang, J., Byers, L. A., Wei, Y., Chapman, H. A., Yamauchi, M., Behrens, C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18298-8 · Cited by 436
Spatially confined sub-tumor microenvironments in pancreatic cancer
Grünwald, B. T., Devisme, A., Andrieux, G., Vyas, F., Aliar, K., McCloskey, C. W., Macklin, A., Jang, G. H., Denroche, R., Romero, J. M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.022 · Cited by 433
Activated fibroblasts in cancer: Perspectives and challenges
Caligiuri, G., & Tuveson, D. A. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.02.015 · Cited by 424
Chen, I. X., Chauhan, V. P., Posada, J., Ng, M. R., Wu, M. W., Adstamongkonkul, P., Huang, P., Lindeman, N., Langer, R., & Jain, R. K. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815515116 · Cited by 406
3D In Vitro Model (R)evolution: Unveiling Tumor–Stroma Interactions
Rodrigues, J., Heinrich, M. A., Teixeira, L. M., & Prakash, J. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2020.10.009 · Cited by 405 · cited 1×
“Therefore, patient-relevant 3D in vitro models based on complex hetero-spheroids, cancer-on-chip models, 3D bioprinting techniques are required to recapitulate human tumor stroma interaction and human tumor ECM (98, 99).”
BackgroundSelf-citationTumour DDR1 promotes collagen fibre alignment to instigate immune exclusion
Sun, X., Wu, B., Chiang, H.-C., Deng, H., Zhang, X., Xiong, W., Liu, J., Rozeboom, A. M., Harris, B. T., Blommaert, E., et al. (2021) · Nature · doi:10.1038/s41586-021-04057-2 · Cited by 401
Cheng, Y., Li, H., Deng, Y., Tai, Y., Zeng, K., Zhang, Y., Liu, W., Zhang, Q., & Yang, Y. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0458-4 · Cited by 399
Modulating extracellular matrix stiffness: A strategic approach to boost cancer immunotherapy
Mai, Z., Lin, Y., Lin, P., Zhao, X., & Cui, L. (2024) · Cell Death & Disease · doi:10.1038/s41419-024-06697-4 · Cited by 398
Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy
Bertero, T., Oldham, W. M., Grasset, E. M., Bourget, I., Boulter, E., Pisano, S., Hofman, P., Bellvert, F., Meneguzzi, G., Bulavin, D. V., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.09.012 · Cited by 393
Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters
Naba, A., Clauser, K. R., Lamar, J. M., Carr, S. A., & Hynes, R. O. (2014) · eLife · doi:10.7554/elife.01308 · Cited by 377
Tumor macrophages are pivotal constructors of tumor collagenous matrix
Afik, R., Zigmond, E., Vugman, M., Klepfish, M., Shimshoni, E., Pasmanik-Chor, M., Shenoy, A., Bassat, E., Halpern, Z., Geiger, T., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151193 · Cited by 375
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
Saatci, O., Kaymak, A., Raza, U., Ersan, P. G., Akbulut, O., Banister, C. E., Sikirzhytski, V., Tokat, U. M., Aykut, G., Ansari, S. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16199-4 · Cited by 368
Nicolas-Boluda, A., Vaquero, J., Vimeux, L., Guilbert, T., Barrin, S., Kantari-Mimoun, C., Ponzo, M., Renault, G., Deptula, P., Pogoda, K., et al. (2021) · eLife · doi:10.7554/elife.58688 · Cited by 368
A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy
Di Martino, J. S., Nobre, A. R., Mondal, C., Taha, I., Farias, E. F., Fertig, E. J., Naba, A., Aguirre-Ghiso, J. A., & Bravo-Cordero, J. J. (2021) · Nature Cancer · doi:10.1038/s43018-021-00291-9 · Cited by 322
Spatial CRISPR genomics identifies regulators of the tumor microenvironment
Dhainaut, M., Rose, S. A., Akturk, G., Wroblewska, A., Nielsen, S. R., Park, E. S., Buckup, M., Roudko, V., Pia, L., Sweeney, R., et al. (2022) · Cell · doi:10.1016/j.cell.2022.02.015 · Cited by 281
Vennin, C., Mélénec, P., Rouet, R., Nobis, M., Cazet, A. S., Murphy, K. J., Herrmann, D., Reed, D. A., Lucas, M. C., Warren, S. C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10968-6 · Cited by 268
Rahbari, N. N., Kedrin, D., Incio, J., Liu, H., Ho, W. W., Nia, H. T., Edrich, C. M., Jung, K., Daubriac, J., Chen, I., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf5219 · Cited by 258
Fattet, L., Jung, H.-Y., Matsumoto, M. W., Aubol, B. E., Kumar, A., Adams, J. A., Chen, A. C., Sah, R. L., Engler, A. J., Pasquale, E. B., et al. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.05.031 · Cited by 245
Matricryptins and matrikines: biologically active fragments of the extracellular matrix
Ricard‐Blum, S., & Salza, R. (2014) · Experimental Dermatology · doi:10.1111/exd.12435 · Cited by 224
Che, L.-H., Liu, J.-W., Huo, J.-P., Luo, R., Xu, R.-M., He, C., Li, Y.-Q., Zhou, A.-J., Huang, P., Chen, Y.-Y., et al. (2021) · Cell Discovery · doi:10.1038/s41421-021-00312-y · Cited by 222
Eikenes, L., Tari, M., Tufto, I., Bruland, Ø. S., & de Lange Davies, C. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602626 · Cited by 221
β1 Integrin Inhibition Dramatically Enhances Radiotherapy Efficacy in Human Breast Cancer Xenografts
Park, C. C., Zhang, H. J., Yao, E. S., Park, C. J., & Bissell, M. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6390 · Cited by 220
Chauhan, V. P., Boucher, Y., Ferrone, C. R., Roberge, S., Martin, J. D., Stylianopoulos, T., Bardeesy, N., DePinho, R. A., Padera, T. P., Munn, L. L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.06.003 · Cited by 204
Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy
Sharma, N. S., Gupta, V. K., Garrido, V. T., Hadad, R., Durden, B. C., Kesh, K., Giri, B., Ferrantella, A., Dudeja, V., Saluja, A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127515 · Cited by 203
Benson, A. B., Wainberg, Z. A., Hecht, J. R., Vyushkov, D., Dong, H., Bendell, J., & Kudrik, F. (2017) · The Oncologist · doi:10.1634/theoncologist.2017-0024 · Cited by 195
Targeted antibody and cytokine cancer immunotherapies through collagen affinity
Ishihara, J., Ishihara, A., Sasaki, K., Lee, S. S.-Y., Williford, J.-M., Yasui, M., Abe, H., Potin, L., Hosseinchi, P., Fukunaga, K., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau3259 · Cited by 190
The pro-tumorigenic host response to cancer therapies
Shaked, Y. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0209-6 · Cited by 181
Self-citationCancer Cell–Derived Matrisome Proteins Promote Metastasis in Pancreatic Ductal Adenocarcinoma
Tian, C., Öhlund, D., Rickelt, S., Lidström, T., Huang, Y., Hao, L., Zhao, R. T., Franklin, O., Bhatia, S. N., Tuveson, D. A., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2578 · Cited by 177
Martins, S. G., Zilhão, R., Þorsteinsdóttir, S., & Carlos, A. R. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.673002 · Cited by 176
Co-evolution of Matrisome and Adaptive Adhesion Dynamics Drives Ovarian Cancer Chemoresistance
Pietilä, E. A., Gonzalez-Molina, J., Moyano-Galceran, L., Jamalzadeh, S., Zhang, K., Lehtinen, L., Turunen, S. P., Martins, T. A., Gultekin, O., Lamminen, T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24009-8 · Cited by 175
Kay, E. J., Paterson, K., Riera-Domingo, C., Sumpton, D., Däbritz, J. H. M., Tardito, S., Boldrini, C., Hernandez-Fernaud, J. R., Athineos, D., Dhayade, S., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00582-0 · Cited by 168
Setälä, L. P., Tammi, M. I., Tammi, R. H., Eskelinen, M. J., Lipponen, P. K., Ågren, U. M., Parkkinen, J., Alhava, E. M., & Kosma, V.-M. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690180 · Cited by 159
Horn, L. A., Chariou, P. L., Gameiro, S. R., Qin, H., Iida, M., Fousek, K., Meyer, T. J., Cam, M. C., Flies, D. B., Langermann, S., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci155148 · Cited by 157
Nguyen, D. H. A., Oketch‐Rabah, H. A., Illa-Bochaca, I., Geyer, F. C., Reis-Filho, J. S., Mao, J., Ravani, S. A., Zavadil, J., Borowsky, A. D., Jerry, D. J., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.03.011 · Cited by 156
Carapuça, E., Gemenetzidis, E., Feig, C., Bapiro, T. E., Williams, M. D., Wilson, A. S., Delvecchio, F. R., Arumugam, P., Grose, R. P., Lemoine, N. R., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4727 · Cited by 139
Stiff stroma increases breast cancer risk by inducing the oncogene ZNF217
Northey, J. J., Barrett, A. S., Acerbi, I., Hayward, M.-K., Talamantes, S., Dean, I. S., Mouw, J. K., Ponik, S. M., Lakins, J. N., Huang, P., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci129249 · Cited by 137
Mutant p53s generate pro-invasive niches by influencing exosome podocalyxin levels
Novo, D., Heath, N., Mitchell, L. E., Caligiuri, G., MacFarlane, A., Reijmer, D., Charlton, L., Knight, J. R. P., Calka, M., McGhee, E. J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07339-y · Cited by 134
Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion
Jiang, H., Liu, X., Knolhoff, B. L., Hegde, S., Lee, K. B., Jiang, H., Fields, R. C., Pachter, J. A., Lim, K.-H., & DeNardo, D. G. (2020) · Gut · doi:10.1136/gutjnl-2018-317424 · Cited by 130
Collagen Density Modulates the Immunosuppressive Functions of Macrophages
Larsen, A. M. H., Kuczek, D. E., Kalviša, A., Siersbæk, M. S., Thorseth, M., Johansen, A. Z., Carretta, M., Grøntved, L., Vang, O., & Madsen, D. H. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900789 · Cited by 127
Houthuijzen, J. M., de Bruijn, R., van der Burg, E., Drenth, A. P., Wientjens, E., Filipovic, T., Bullock, E., Brambillasca, C. S., Pulver, E. M., Nieuwland, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35793-w · Cited by 120
Tissue Transglutaminase Mediated Tumor–Stroma Interaction Promotes Pancreatic Cancer Progression
Lee, J., Condello, S., Yakubov, B., Emerson, R. E., Caperell–Grant, A., Hitomi, K., Xie, J., & Matei, D. E. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0226 · Cited by 105
Fang, S., Dai, Y., Mei, Y., Yang, M., Hu, L., Yang, H., Guan, X., & Li, J. (2019) · Thoracic Cancer · doi:10.1111/1759-7714.12947 · Cited by 105
Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases
Rachman-Tzemah, C., Zaffryar‐Eilot, S., Grossman, M., Ribero, D., Timaner, M., Mäki, J. M., Myllyharju, J., Bertolini, F., Hershkovitz, D., Sagi, I., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.04.005 · Cited by 103
Self-citationPicozzi, V. J., Alseidi, A. A., Winter, J., Pishvaian, M. J., Mody, K., Glaspy, J. A., Larson, T. G., Matrana, M. R., Carney, M., Porter, S., et al. (2020) · ESMO Open · doi:10.1136/esmoopen-2019-000668 · Cited by 102
T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
Haj-Shomaly, J., Vorontsova, A., Barenholz‐Cohen, T., Levi-Galibov, O., Devarasetty, M., Timaner, M., Raviv, Z., Cooper, T. J., Söker, S., Hasson, P., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1012 · Cited by 82
Self-citationMatricryptins Network with Matricellular Receptors at the Surface of Endothelial and Tumor Cells
Ricard‐Blum, S., & Vallet, S. D. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00011 · Cited by 77
Neutrophil Elastase Facilitates Tumor Cell Intravasation and Early Metastatic Events
Deryugina, E. I., Carré, A., Ardi, V. C., Muramatsu, T., Schmidt, J., Pham, C. T., & Quigley, J. P. (2020) · iScience · doi:10.1016/j.isci.2020.101799 · Cited by 76
Integrin-mediated cancer progression as a specific target in clinical therapy
Chen, J.-R., Zhao, J.-T., & Xie, Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113745 · Cited by 75
Fatherree, J. P., Guarin, J. R., McGinn, R. A., Naber, S. P., & Oudin, M. J. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-1823 · Cited by 68
Advances on the roles of tenascin-C in cancer
Yilmaz, A., Loustau, T., Salomé, N., Surendran, S. P., Li, C., Tucker, R. P., Izzi, V., Lamba, R., Koch, M., & Orend, G. (2022) · Journal of Cell Science · doi:10.1242/jcs.260244 · Cited by 66
Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation
Yoo, K.-C., Suh, Y., An, Y., Lee, H., Jeong, Y. J., Uddin, N., Cui, Y., Roh, T. H., Shim, J., Chang, J. H., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0199-y · Cited by 62
Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer
Andriani, F., Landoni, E., Mensah, M., Facchinetti, F., Miceli, R., Tagliabue, E., Giussani, M., Callari, M., Cecco, L. D., Colombo, M. P., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4772-0 · Cited by 62
Gonzalez‐Molina, J., Moyano‐Galceran, L., Single, A., Gultekin, O., Alsalhi, S., & Lehti, K. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.012 · Cited by 58
Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance
Darvishi, B., Eisavand, M. R., Majidzadeh‐A, K., & Farahmand, L. (2022) · British Journal of Cancer · doi:10.1038/s41416-021-01680-8 · Cited by 56
Tumor-associated fibrosis impairs the response to immunotherapy
Naik, A., & Leask, A. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.04.002 · Cited by 49
Nissen, N. I., Johansen, A. Z., Chen, I. M., Johansen, J. S., Pedersen, R. S., Hansen, C. P., Karsdal, M. A., & Willumsen, N. (2022) · Cancers · doi:10.3390/cancers14030819 · Cited by 45
Prometastatic secretome trafficking via exosomes initiates pancreatic cancer pulmonary metastasis
Ogawa, K., Lin, Q., Li, L., Bai, X., Chen, X., Chen, H., Kong, R., Wang, Y., Zhu, H., He, F., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.039 · Cited by 41
Li, L., Zhao, S., Liu, Z., Zhang, N., Pang, S., Liu, J., Liu, C., & Fan, Y. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03511-3 · Cited by 39
Neutrophil granulocytes influence on extracellular matrix in cancer progression
Strøbech, J. E., Giuriatti, P., & Erler, J. T. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00122.2022 · Cited by 30
Gong, L., Zhang, Y., Yang, Y., Yan, Q., Ren, J., Luo, J., Tiu, Y. C., Fang, X., Liu, B., Lam, R. H. W., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.1966 · Cited by 28
The microenvironment and resistance to personalized cancer therapy
Masuda, S., & Belmonte, J. C. I. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.127-c1 · Cited by 26
Cao, Y., Chen, H., Sun, Y. L., Fan, Z., & Cheng, H. H. (2022) · Bioengineered · doi:10.1080/21655979.2022.2062530 · Cited by 26
Human T cells stimulate fibroblast-mediated degradation of extracellular matrix in vitro
Mikko, M., Fredriksson, K., Wahlström, J., Eriksson, P. O., Grünewald, J., & Sköld, C. M. (2007) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2007.03565.x · Cited by 24
Self-organization in cancer: Implications for histopathology, cancer cell biology, and metastasis
Muthuswamy, S. K. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.01.010 · Cited by 24
Radiation Effects on Brain Extracellular Matrix
Витальевна, Г. Э. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.576701 · Cited by 22
Yamagata, A., Yokoyama, T., Fukuda, Y., & Ishida, T. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04205-x · Cited by 22
Targeting integrin α2 as potential strategy for radiochemosensitization of glioblastoma
Korovina, I., Vehlow, A., Temme, A., & Cordes, N. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac237 · Cited by 20
Cited by
Advances in molecular pathology and therapy of non-small cell lung cancer
Huang, Q., Li, Y., Huang, Y., Wu, J., Bao, W., Xue, C., Li, X., Dong, S., Dong, Z., & Hu, S. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02243-6 · Cited by 197
Shah, S., & D’Souza, G. G. M. (2025) · Cells · doi:10.3390/cells14100732 · Cited by 83
Nuclear envelope proteins, mechanotransduction, and their contribution to breast cancer progression
Henretta, S., & Lammerding, J. (2025) · npj Biological Physics and Mechanics · doi:10.1038/s44341-025-00018-2 · Cited by 19
Enhancing radiotherapy techniques for Triple-Negative breast cancer treatment
Sarlak, S., Pagès, G., & Luciano, F. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.102939 · Cited by 19
Metadata
- Authors
- Prakash, J., & Shaked, Y.
- Venue
- Cancer Discovery
- Published
- 2024-08-02
- Volume
- 14
- Issue
- 8
- Pages
- 1375-1388
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- OpenAlex
- W4401274889
- Cited by
- 366
- References
- 101
- FWCI
- 69.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.